Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Molecular Cancer Therapeutics
|
April 22, 2010
Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling
Jonathan M Levitt, Hideyuki Yamashita, Weiguo Jian, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine
Weiguo Jian, Hideyuki Yamashita, Jonathan M Levitt, et al.
Plos One
|
October 15, 2016
MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity
Matthew R Collinson-Pautz, Kevin M Slawin, Jonathan M Levitt, et al.
Nano Letters
|
November 8, 2013
Superresolution microscopy with quantum emitters
Osip Schwartz, Jonathan M Levitt, Ron Tenne, et al.
ACS Nano
|
September 21, 2012
Colloidal quantum dots as saturable fluorophores
Osip Schwartz, Ron Tenne, Jonathan M Levitt, et al.
Optics Letters
|
November 21, 2007
Diagnostic cellular organization features extracted from autofluorescence images
Jonathan M Levitt, Martin Hunter, Claudia Mujat, et al.
International Immunopharmacology
|
March 24, 2004
Sulfur mustard primes phagocytosis and degranulation in human polymorphonuclear leukocytes
Ashley K Vavra, Cecilia J Laurent, Vinh Ngo, et al.
Biomaterials
|
March 4, 2008
Non-invasive optical characterization of biomaterial mineralization
Sharad Gupta, Martin Hunter, Peggy Cebe, et al.
Journal of Biomedical Optics
|
January 11, 2007
Intrinsic fluorescence and redox changes associated with apoptosis of primary human epithelial cells
Jonathan M Levitt, Amy Baldwin, Antonios Papadakis, et al.
The Journal of Clinical Investigation
|
March 9, 2011
A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy
Priyadharshini Narayanan, Natalia Lapteva, Mamatha Seethammagari, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Molecular Cancer Therapeutics
|
April 22, 2010
Dasatinib is preclinically active against Src-overexpressing human transitional cell carcinoma of the urothelium with activated Src signaling
Jonathan M Levitt, Hideyuki Yamashita, Weiguo Jian, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine
Weiguo Jian, Hideyuki Yamashita, Jonathan M Levitt, et al.
Plos One
|
October 15, 2016
MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity
Matthew R Collinson-Pautz, Kevin M Slawin, Jonathan M Levitt, et al.
Nano Letters
|
November 8, 2013
Superresolution microscopy with quantum emitters
Osip Schwartz, Jonathan M Levitt, Ron Tenne, et al.
ACS Nano
|
September 21, 2012
Colloidal quantum dots as saturable fluorophores
Osip Schwartz, Ron Tenne, Jonathan M Levitt, et al.
Optics Letters
|
November 21, 2007
Diagnostic cellular organization features extracted from autofluorescence images
Jonathan M Levitt, Martin Hunter, Claudia Mujat, et al.
International Immunopharmacology
|
March 24, 2004
Sulfur mustard primes phagocytosis and degranulation in human polymorphonuclear leukocytes
Ashley K Vavra, Cecilia J Laurent, Vinh Ngo, et al.
Biomaterials
|
March 4, 2008
Non-invasive optical characterization of biomaterial mineralization
Sharad Gupta, Martin Hunter, Peggy Cebe, et al.
Journal of Biomedical Optics
|
January 11, 2007
Intrinsic fluorescence and redox changes associated with apoptosis of primary human epithelial cells
Jonathan M Levitt, Amy Baldwin, Antonios Papadakis, et al.
The Journal of Clinical Investigation
|
March 9, 2011
A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy
Priyadharshini Narayanan, Natalia Lapteva, Mamatha Seethammagari, et al.
Page
of 4